Breaking News

BioNTech SE Receives Pandemic Preparedness Contract in Germany

The company will reserve and maintain manufacturing capabilities to produce at least 80 million mRNA-based vaccine doses per year.

Author Image

By: Charlie Sternberg

Associate Editor

BioNTech SE has been granted a pandemic preparedness contract by the Federal Republic of Germany. The framework agreement is aimed at pandemic preparedness including manufacturing and supply of mRNA vaccines in emergency situations in Germany.   “There is growing evidence that viral pandemics will continue to pose a public health challenge for years. This contract with the German government will ensure significant supply of vaccine doses to address potential public health threats by 2027,” sai...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters